Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)

NCT06908785 is registered in ClinicalTrials.gov with Instituto de Investigación Marqués de Valdecilla as lead sponsor.

NCT NCT06908785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06908785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)
Lead sponsor
Instituto de Investigación Marqués de Valdecilla
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2025
Completion date
September 1, 2028
Enrollment
330 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver